Pharmidex attending the Global Business Accelerator visit to Switzerland
March 10, 2018

Pharmidex will be attending the Global Business Accelerator Program which is run by the Enterprise Europe Network and supported by Innovate UK.

The Enterprise Europe Network, supported by Innovate UK, are visiting Switzerland to focus on the pharmaceutical technology industry. The chosen companies will have the opportunity to meet pharmaceutical companies and key stakeholders based in Basel and attend ProcureCon Pharma in Zürich for the next three days


The Swiss pharmaceutical sector is a major employer with more than 40,000 people working directly for the industry. If the indirect work created through ancillary industries is included, as many as 172,000 jobs are related to the pharmaceutical industry. In addition, it accounts for up to a third of all Swiss exports, and the productivity of the industry is four times as high as that of the economy as a whole.


Three big clusters – the Lake Geneva area, the Basel region and Zürich-Zug-Lucerne – account for the lion’s share of the gross value added of the Swiss pharmaceutical industry and present many collabartive opputunities for UK companies. 


During the trip Pharmidex will also be attending ProcureCon Pharma, organised by Worldwide Business Research, will take place from 13 to 15 March 2018 in Zürich. Delegates will have the opportunity to join 200 senior procurement professionals from Merck, Astra Zeneca, Roche, Sanofi, Lonza and other world-leading pharmaceutical businesses over three days. 


We look forward to meeting you there.

June 17, 2026
On 18 June, our COO, Ash Alavijeh , will join an industry panel discussing: "What are the advantages and disadvantages of working with UK-based Discovery CROs?" The session will explore the value of UK CROs in supporting innovation, protecting IP, accessing scientific expertise and accelerating drug discovery programmes. ๐Ÿ“… 18 June 2025 ๐Ÿ“ Cambridge ๐Ÿ•’ Panel Session: 12:20–12:45 We look forward to connecting with colleagues, collaborators, and innovators from across the life sciences community.
June 16, 2026
This well-deserved appointment marks an important milestone in a remarkable career spanning more than 22 years at Pharmidex . Over the years, Dr Chishty has made a significant contribution to the growth of our DMPK capabilities, applying his extensive expertise in Drug Metabolism and Pharmacokinetics to support successful drug discovery and development programmes for clients worldwide. His scientific leadership, dedication and commitment to excellence have been instrumental in strengthening our services and supporting the continued success of Pharmidex . As we continue to grow and support innovative biopharmaceutical companies, we look forward to the impact Dr Chishty will make in this new role. Please join us in congratulating Dr Mansoor Chishty on this achievement and wishing him every success as Director of DMPK.
June 12, 2026
At Pharmidex , we know that great teams are built through collaboration, resilience and shared experiences. Our recent football event brought colleagues together to promote wellbeing, encourage physical activity and strengthen the relationships that help us succeed both on the pitch and in the laboratory. The qualities that drive success in sport, teamwork, dedication and determination are the same values that underpin scientific excellence every day at Pharmidex . As the world looks ahead to the excitement of World Football 2026, we're proud to celebrate the positive impact sport has in bringing people together, inspiring healthy lifestyles, and creating stronger communities. ๐Ÿ”ฌ Advancing science ๐Ÿค Building stronger teams ๐Ÿ’ช Promoting wellbeing โšฝ Celebrating our passion for sport And while football fans may be singing "It's coming home"... at Pharmidex we're convinced that "It's coming lab!" ๐Ÿงชโšฝ From the pitch to the lab, we're proud to champion teamwork, innovation, and a shared passion for achieving great results.
More Posts